These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 26356511)
1. [Variants of changes in the psychopathological phenomenology of the long-term remission in stable patients with attack-like progressive form of schizophrenia: a longitudinal study]. Morozova MA; Burminskiy DS; Rupchev GE Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):22-29. PubMed ID: 26356511 [TBL] [Abstract][Full Text] [Related]
2. [Psychopathology of schizophrenia and brain imaging]. Gross G; Huber G Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545 [TBL] [Abstract][Full Text] [Related]
3. [Changes in the relationship between cognitive functioning and psychopathological symptoms in patients with paranoid schizophrenia in the periods of psychosis and development of remission]. Morozova MA; Lepilkina TA; Rubashkina VV Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(7):4-12. PubMed ID: 18833111 [TBL] [Abstract][Full Text] [Related]
4. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Helldin L; Kane JM; Karilampi U; Norlander T; Archer T Schizophr Res; 2007 Jul; 93(1-3):160-8. PubMed ID: 17395430 [TBL] [Abstract][Full Text] [Related]
5. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment. Plesnicar BK; Zalar B; Breskvar K; Dolzan V J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753 [TBL] [Abstract][Full Text] [Related]
6. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment]. Lecardeur L; Meunier-Cussac S; Dollfus S Encephale; 2013 May; 39 Suppl 1():S64-71. PubMed ID: 23528322 [TBL] [Abstract][Full Text] [Related]
7. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study. Novick D; Haro JM; Suarez D; Vieta E; Naber D Schizophr Res; 2009 Mar; 108(1-3):223-30. PubMed ID: 19070991 [TBL] [Abstract][Full Text] [Related]
8. [Modification of long-term schizophrenia by somato-therapeutic measures]. Gross G; Huber G; Schüttler R Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621 [TBL] [Abstract][Full Text] [Related]
9. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study. Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905 [TBL] [Abstract][Full Text] [Related]
10. Psychopharmacotherapy and remission of patients with schizophrenia. Degmecić D; Pozgain I; Filaković P; Dodig-Curković K; Mihanović M Coll Antropol; 2009 Jun; 33(2):547-51. PubMed ID: 19662777 [TBL] [Abstract][Full Text] [Related]
11. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission. Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246 [TBL] [Abstract][Full Text] [Related]
12. [The European Schizophrenia Outpatient Health Outcomes Study: observational study over 36 months of the French cohort of schizophrenic outpatients treated with antipsychotics]. Gasquet I; Chartier F; Tcherny-Lessenot S; Lépine JP Rev Epidemiol Sante Publique; 2009 Feb; 57(1):25-32. PubMed ID: 19162420 [TBL] [Abstract][Full Text] [Related]
13. Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study. Harrow M; Jobe TH; Faull RN Psychol Med; 2012 Oct; 42(10):2145-55. PubMed ID: 22340278 [TBL] [Abstract][Full Text] [Related]
14. A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial. Stahl SM; Malla A; Newcomer JW; Potkin SG; Weiden PJ; Harvey PD; Loebel A; Watsky E; Siu CO; Romano S J Clin Psychopharmacol; 2010 Aug; 30(4):425-30. PubMed ID: 20571437 [TBL] [Abstract][Full Text] [Related]
15. [Maintenance pharmacotherapy of schizophrenia: remission and the effectiveness of long-acting risperidone therapy]. Sárosi A Neuropsychopharmacol Hung; 2006 Dec; 8(4):179-87. PubMed ID: 17211053 [TBL] [Abstract][Full Text] [Related]
16. Lower subjective quality of life and the development of social anxiety symptoms after the discharge of elderly patients with remitted schizophrenia: a 5-year longitudinal study. Kumazaki H; Kobayashi H; Niimura H; Kobayashi Y; Ito S; Nemoto T; Sakuma K; Kashima H; Mizuno M Compr Psychiatry; 2012 Oct; 53(7):946-51. PubMed ID: 22554765 [TBL] [Abstract][Full Text] [Related]
17. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice]. Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study. Barrio P; Batalla A; Castellví P; Hidalgo D; García M; Ortiz A; Grande I; Pons A; Parellada E Int Clin Psychopharmacol; 2013 Jul; 28(4):164-70. PubMed ID: 23587986 [TBL] [Abstract][Full Text] [Related]
19. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720 [TBL] [Abstract][Full Text] [Related]
20. Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment. Zeng B; Ardekani BA; Tang Y; Zhang T; Zhao S; Cui H; Fan X; Zhuo K; Li C; Xu Y; Goff DC; Wang J Schizophr Res; 2016 Apr; 172(1-3):1-8. PubMed ID: 26852402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]